SCHEMBL5748375

SCHEMBL5748375

C/C=C/CCC(C)CN1CCN(c2ccccc2Cl)CC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.49
DRD3 P35462 6/20 0.49
IGF1R P08069 1/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 1/20 0.46
PLA2G1B P04054 1/20 0.46
RAB9A P51151 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
HTR1A P08908 5/20 0.45
LMNA P02545 1/20 0.45
HTR7 P34969 1/20 0.44
DRD4 P21917 2/20 0.41
ADRA1B P35368 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5748386 1.00 DRD2 (0.49) DRD2DRD3IGF1RKDM4EALDH1A1
SCHEMBL5748380 0.74 SMN1; SMN2 (0.38) KDM4EALDH1A1PLA2G1BRAB9AATG4B
SCHEMBL5745562 0.74 MEN1 (0.45) DRD2DRD3ALDH1A1HTR1ALMNA
SCHEMBL5745558 0.74 MEN1 (0.45) DRD2DRD3ALDH1A1HTR1ALMNA
SCHEMBL16063427 0.69 DRD2 (0.71) DRD2DRD3IGF1RHTR1ADRD4
SCHEMBL9565835 0.69 KDM4E (0.66) DRD2DRD3KDM4EALDH1A1PLA2G1B
SCHEMBL10533306 0.69 IGF1R (0.62) DRD2DRD3IGF1RKDM4EALDH1A1
SCHEMBL28396664 0.68 ADRB1 (0.71) DRD2DRD3KDM4EALDH1A1PLA2G1B
SCHEMBL13898923 0.66 ADRB1 (0.53) DRD2DRD3KDM4EALDH1A1PLA2G1B
SCHEMBL30001672 0.65 HTR7 (0.75) KDM4EALDH1A1LMNAHTR7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673089-A2 PHENYL-PIPERAZINE DERIVATIVES AS MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmaceuticals Incorporated (US) 2006-06-28 EP disclosed
WO-2005030188-A2 PHENYL-PIPERAZINE DERIVATIVES AS MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-04-07 WO disclosed